Contact Us: 877-541-3263

Email

CALL

tulchin_harris_e_esq

Always Evolving and Adapting

Counsel for SPAC Sponsors

Strategic legal guidance for SPAC sponsors in de-SPAC transactions. Anthony, Linder & Cacomanolis provides expert analysis of the Subpart 1600 of Regulation S-K disclosure mandates, sponsor promote dilution, and fiduciary liability under the 2024 SEC rules.

Counsel for SPAC Sponsors: Navigating Subpart 1600 and the de-SPAC Evolution

In the refined regulatory landscape of 2024 and 2025, the role of the SPAC sponsor has transitioned from a purely entrepreneurial endeavor to one of heightened fiduciary and disclosure accountability. The SEC’s adoption of the de-SPAC rules has fundamentally altered the economics and liability profile of the sponsor. Anthony, Linder & Cacomanolis provides sophisticated counsel to SPAC sponsors, ensuring that their “promote” structures, voting commitments, and conflict disclosures satisfy the rigorous requirements of the federal securities laws and exchange listing standards.

Subpart 1600 of Regulation S-K: The New Disclosure Standard

The cornerstone of the 2024 regulatory shift is the implementation of Subpart 1600 of Regulation S-K. These rules mandate a level of transparency regarding the sponsor’s interests and the fairness of the business combination that mirrors traditional underwritten IPO standards.

Item 1603: SPAC Sponsor and Conflicts of Interest

Item 1603 requires exhaustive disclosure regarding the sponsor, its affiliates, and any promoters of the SPAC. The SEC staff now expects a “granular and plain-English” description of every material conflict that could influence the sponsor’s decision to recommend a transaction.

  • Compensation and Interests: All compensation that has been or will be awarded to, earned by, or paid to the sponsor, its affiliates, and any promoters in connection with the de-SPAC transaction. This includes the “promote” (Class B shares), the private placement warrants, and any “indirect” compensation such as fees paid to affiliates for consulting or placement agent services.
  • Detailed Conflict of Interest Analysis (Item 1603(b)): The disclosure must move beyond boilerplate language to address the following structural conflicts:
    • Contingent Nature of the Promote: Disclosure of the “all-or-nothing” incentive, where the sponsor’s equity and warrants (often purchased for a nominal sum) will become worthless if a combination is not closed by the deadline. This creates a material incentive to close any deal, regardless of quality, to avoid total loss.
    • Disparate Returns: A technical analysis showing that the sponsor may realize a significant positive return on its investment even if the post-combination share price trades substantially below the $10.00 IPO price, while public shareholders experience a loss.
    • Target-Specific Conflicts: Disclosure of whether the sponsor or its affiliates have any material interest in the target company or are participating in any side-car investments or PIPE financings that provide them with terms more favorable than those offered to public shareholders.
    • Competing Interests: A description of any other SPACs or business ventures managed by the sponsor that are seeking similar target companies, and how the sponsor determines which entity will be presented with a specific corporate opportunity.
  • Fiduciary Duties: A description of any fiduciary duties that the sponsor’s officers and directors owe to other entities, which might compete with the SPAC for the target company. This must include an explanation of the “priority” of these duties and how they were managed during the target identification process.

Item 1604: Fairness of the Business Combination

Under Item 1604, the registration statement must disclose whether the SPAC board of directors believes that the business combination and any related financing (such as a PIPE) are fair or unfair to the SPAC’s unaffiliated shareholders.

  • The Sponsor’s Role in Fairness: While the board makes the formal determination, the sponsor is typically the party negotiating the valuation and the terms. Item 1604 requires the disclosure of the material factors upon which the fairness belief is based.
  • Reports and Opinions (Item 1607): If the sponsor or the board receives any report, opinion, or appraisal from an outside party (such as a fairness opinion), Item 1607 requires the filing of that document as an exhibit and a detailed summary of its findings.

Item 1609: Projections in de-SPAC Transactions

One of the most significant shifts for sponsors is the loss of the PSLRA safe harbor for forward-looking statements in de-SPAC transactions.

  • Mandatory Disclosures: Pursuant to Item 1609, if projections are used, the company must disclose the material bases and assumptions underlying those projections and whether the projections still reflect the view of the board or management as of the date of the filing.
  • Duty to Update: Sponsors must be prepared to update or correct projections if they are no longer reasonable, a requirement that increases the litigation risk profile of the transaction.

The Sponsor “Promote” and Dilution Sensitivity Analysis

Subpart 1600 places a heavy emphasis on the dilutive impact of the sponsor’s equity. Registration statements must now include a “Dilution Sensitivity Table” that demonstrates the impact on the per-share value of public shareholders across multiple redemption levels (e.g., 0%, 25%, 50%, 75%, and maximum redemptions).

Managing the Promote (Class B Shares)

The typical 20% “promote” is under intense scrutiny. Anthony, Linder & Cacomanolis assists sponsors in structuring:

  • Incentive Alignment: Implementing “earn-out” structures where the sponsor’s shares remain restricted or are forfeited unless the post-merger company meets specific stock price or operational targets.
  • Forfeiture and Transfer: Negotiating the partial forfeiture of the promote to satisfy the valuation requirements of the target company or to induce PIPE investment.
  • Warrant Restructuring: Evaluating the conversion or redemption of private placement warrants to simplify the post-closing capital structure and reduce the overall overhang.

Sponsor Support and Voting Agreements

The sponsor’s commitment to the transaction is codified in the Sponsor Support Agreement (also known as a Voting and Support Agreement). Key considerations include:

  • The 139.29 Safe Harbor: As discussed in our analysis of insider lock-up agreements (see https://www.legalandcompliance.com/securities-law/insider-lock-up-agreements/), the sponsor’s entry into a voting agreement must be structured to fit within the CDI 139.29 safe harbor to ensure the transaction can be registered on Form S-4 or F-4.
  • Waiver of Redemption Rights: Sponsors must explicitly waive their rights to redeem their shares in connection with the de-SPAC transaction, a provision that is now a mandatory disclosure under the 2024 rules.
  • Lock-Up and Leak-Out Mandates: Institutional investors and target companies often demand that the sponsor’s lock-up be equal to or longer than that of the target’s founders (often one year) to signal long-term commitment.

Fiduciary Duties and State Law Considerations

Most SPACs are incorporated in Delaware or Nevada. The sponsor, through its control of the board, faces significant fiduciary duty exposure, particularly regarding “Conflicts of Interest” and “Corporate Opportunities.”

  • Entire Fairness Standard: In Delaware, if a majority of the board is deemed to be “interested” (often due to their affiliation with the sponsor), the transaction may be subject to the “Entire Fairness” standard of review rather than the more deferential “Business Judgment Rule.”
  • Special Committees: We often advise sponsors to recommend the formation of a special committee of independent directors to negotiate the transaction and obtain a third-party fairness opinion to insulate the deal from future shareholder litigation.

Authority Through Professional Experience

Our firm’s expertise in representing SPAC sponsors is grounded in a deep understanding of the capital markets and the evolution of SEC enforcement. We invite sponsors and their management teams to explore our archive of insights at our corporate website and our specialized blog site, www.securitieslawblog.com, for detailed discussions on the 2024 de-SPAC rules and the impact of Rule 145a on sponsor liability.

Schedule an Executive Strategy Consultation

The de-SPAC process is a high-stakes transition that requires an authoritative partner who understands the intersection of sponsor economics and regulatory compliance. Anthony, Linder & Cacomanolis invites SPAC sponsors and their leadership teams to engage in a high-level strategy consultation to ensure your transaction is structured for success.

Schedule an executive strategy consultation with our senior partners to discuss your sponsor representation needs by calling 877-541-3263 or visiting our contact page.